New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin

QR Code

New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin

Baptist GallwitzDept Medicine IV, T&uuml;bingen University, Otfried-M&uuml;ller-Str, 10, 72076 T&uuml;bingen, GermanyAbstract: Saxagliptin is a novel dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitor) for the treatment of type 2 diabetes, with a duration profile for once dail...

Full description

Saved in:

Bibliographic Details
Main Author:	Baptist Gallwitz
Format:	article
Language:	EN
Published:	Dove Medical Press 2010
Subjects:	Specialties of internal medicine RC581-951
Online Access:	https://doaj.org/article/7c898e859a724600b3976e93c46cb673
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin
by: Gallwitz B
Published: (2010)

Saxagliptin for type 2 diabetes
by: Antonio R Chacra, et al.
Published: (2010)

Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes
by: Maffioli P, et al.
Published: (2011)

Saxagliptin for type 2 diabetes
by: Chacra
Published: (2010)

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
by: Jason Seewoodhary, et al.
Published: (2010)

Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes
by: Gallwitz B
Published: (2013)

Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics
by: Jean-Pierre Le Floch
Published: (2010)

Risk management in the treatment of type 2 diabetes with pioglitazone
by: Giuseppe Derosa, et al.
Published: (2009)

Emerging use of combination therapies for the management of type 2 diabetes – focus on saxagliptin and dapagliflozin
by: Yu H, et al.
Published: (2017)

Type 2 diabetes in Brazil: epidemiology and management
by: Almeida-Pititto B, et al.
Published: (2015)

Comparative effectiveness of liraglutide in the treatment of type 2 diabetes
by: Rigato M, et al.
Published: (2014)

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
by: Joshua J Neumiller, et al.
Published: (2010)

Fixed combination of repaglinide and metformin in the management of type 2 diabetes
by: Robert Moses
Published: (2009)

Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations
by: Uy J, et al.
Published: (2012)

Insulin detemir for the treatment of obese patients with type 2 diabetes
by: Hollander PA
Published: (2012)

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
by: Shannon A Miller, et al.
Published: (2009)

Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
by: Rosak C, et al.
Published: (2012)

Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia
by: Anderson M, et al.
Published: (2014)

Clinical potential of sodium-glucose cotransporter 2 inhibitors in the management of type 2 diabetes
by: Kim Y, et al.
Published: (2012)

Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment
by: Scott D
Published: (2013)

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
by: Stanley S Schwartz
Published: (2010)

Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: current evidence
by: Sosale A, et al.
Published: (2015)

Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes
by: Kishimoto M
Published: (2013)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
by: Holl, et al.
Published: (2014)

Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes
by: Jonathan K Reynolds
Published: (2009)

Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability
by: Nishio S, et al.
Published: (2015)

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
by: AlMaatouq MA
Published: (2012)

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
by: Lorber D
Published: (2014)

Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy
by: Amy Fleischman, et al.
Published: (2009)

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
by: Al Sifri S
Published: (2012)

Long-term safety and efficacy of insulin degludec in the management of type 2 diabetes
by: Thuillier P, et al.
Published: (2015)

Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus
by: Whaley JM, et al.
Published: (2012)

Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus
by: Petersen AB, et al.
Published: (2013)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated
by: Irons BK, et al.
Published: (2014)

Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
by: Paul Valensi
Published: (2009)

Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting
by: Ofori SN, et al.
Published: (2014)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
by: Irons BK, et al.
Published: (2017)

Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes
by: Mann KV, et al.
Published: (2014)

Potential role of linagliptin as an oral once-daily treatment for patients with type 2 diabetes
by: Hoimark L, et al.
Published: (2012)

Recent results of exenatide use as adjunctive therapy in the treatment of patients with type 2 diabetes
by: Peggy Soule Odegard, et al.
Published: (2009)